J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea · Delayed Price · Currency is KRW 8,400.00
-190.00 (-2.21%)
At close: Nov 14, 2025
J2KBIO Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 2,247 | -1,653 | 4,844 | 2,086 | 1,623 | 1,475 |
Depreciation & Amortization | 1,118 | 1,118 | 634.44 | 556.88 | 506.57 | 334.45 |
Loss (Gain) From Sale of Assets | 4.58 | 4.58 | - | 39.95 | - | - |
Asset Writedown & Restructuring Costs | - | - | 6.74 | - | 99.33 | - |
Loss (Gain) From Sale of Investments | -85.7 | -85.7 | -36.58 | 64.4 | - | - |
Provision & Write-off of Bad Debts | -63.27 | -63.27 | 98.9 | 93.33 | 107.18 | 241.33 |
Other Operating Activities | 660.64 | 4,896 | 711.6 | 13.8 | 327.93 | -88.68 |
Change in Accounts Receivable | 2,733 | 2,733 | -3,302 | -789.83 | 177.25 | -409.45 |
Change in Inventory | 224.86 | 224.86 | -690.72 | -1,037 | -344.33 | -158.41 |
Change in Accounts Payable | -53.35 | -53.35 | 907.14 | 81.61 | -189.81 | -490.82 |
Change in Unearned Revenue | - | - | - | - | 1.2 | - |
Change in Income Taxes | - | - | - | - | - | -366.35 |
Change in Other Net Operating Assets | -4,958 | -193.43 | 111.9 | 338.59 | -307.1 | 314.71 |
Operating Cash Flow | 1,828 | 6,928 | 3,285 | 1,448 | 2,001 | 852.27 |
Operating Cash Flow Growth | -70.67% | 110.88% | 126.92% | -27.66% | 134.83% | - |
Capital Expenditures | -1,145 | -6,904 | -1,369 | -119.66 | -798.8 | -1,865 |
Sale of Property, Plant & Equipment | - | - | - | 31.82 | - | - |
Cash Acquisitions | - | 10,580 | - | - | - | - |
Divestitures | - | - | - | - | 55.31 | - |
Sale (Purchase) of Intangibles | -93.15 | -83.79 | -217.52 | -60.54 | -16.98 | -146.46 |
Sale (Purchase) of Real Estate | -103.31 | -36.17 | - | - | -35.71 | -3.97 |
Investment in Securities | -2,321 | -5,950 | 993.47 | -1,001 | - | - |
Other Investing Activities | -530.8 | -672.09 | -1.37 | -15.88 | -458.61 | 33.27 |
Investing Cash Flow | -4,194 | -3,067 | -594.58 | -1,165 | -1,255 | -1,835 |
Short-Term Debt Issued | - | - | 1,600 | - | - | 200 |
Long-Term Debt Issued | - | - | 700 | 200 | 500 | 1,620 |
Total Debt Issued | - | - | 2,300 | 200 | 500 | 1,820 |
Short-Term Debt Repaid | - | -100 | -1,500 | -15.6 | -201.65 | -300 |
Long-Term Debt Repaid | - | -704.38 | -3,075 | -1,158 | -1,206 | -615.37 |
Total Debt Repaid | -546.79 | -804.38 | -4,575 | -1,174 | -1,408 | -915.37 |
Net Debt Issued (Repaid) | -546.79 | -804.38 | -2,275 | -973.96 | -908.01 | 904.72 |
Repurchase of Common Stock | - | -23.77 | - | - | - | - |
Dividends Paid | -1,147 | - | -240.22 | - | - | - |
Other Financing Activities | 0 | -3.8 | -0 | - | 0 | -0 |
Financing Cash Flow | -1,693 | -831.95 | -2,515 | -973.96 | 1,092 | 904.72 |
Foreign Exchange Rate Adjustments | 8.62 | 9.45 | -0.02 | - | -0.02 | -0.73 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | -0 | -0 | -0 | -0 |
Net Cash Flow | -4,050 | 3,038 | 175.69 | -691.59 | 1,839 | -79.18 |
Free Cash Flow | 683.18 | 23.37 | 1,916 | 1,328 | 1,203 | -1,013 |
Free Cash Flow Growth | - | -98.78% | 44.27% | 10.43% | - | - |
Free Cash Flow Margin | 2.20% | 0.07% | 6.73% | 8.28% | 8.46% | -7.31% |
Free Cash Flow Per Share | 117.86 | 4.24 | 380.01 | 263.40 | 19442.01 | -16377.58 |
Cash Interest Paid | 57.26 | 68.8 | 119.2 | 108.54 | 42.21 | 115.92 |
Cash Income Tax Paid | 176.97 | 928.79 | 138.34 | 85.19 | -73 | 89.17 |
Levered Free Cash Flow | -644.88 | -1,615 | -752.45 | 269.87 | 1,534 | - |
Unlevered Free Cash Flow | -644.88 | -1,555 | -642.15 | 431.3 | 1,660 | - |
Change in Working Capital | -2,053 | 2,711 | -2,974 | -1,407 | -662.79 | -1,110 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.